KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Debt (2018 - 2024)

BioNTech SE's Non-Current Debt history spans 7 years, with the latest figure at $50.1 million for Q4 2024.

  • For Q4 2024, Non-Current Debt rose 20.05% year-over-year to $50.1 million; the TTM value through Dec 2024 reached $50.1 million, up 20.05%, while the annual FY2024 figure was $50.8 million, 20.95% up from the prior year.
  • Non-Current Debt for Q4 2024 was $50.1 million at BioNTech SE, up from $41.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $196.3 million in Q4 2021 and bottomed at $6.2 million in Q4 2022.
  • The 5-year median for Non-Current Debt is $41.7 million (2023), against an average of $66.4 million.
  • The largest annual shift saw Non-Current Debt plummeted 96.83% in 2022 before it surged 570.79% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $37.6 million in 2020, then surged by 422.68% to $196.3 million in 2021, then tumbled by 96.83% to $6.2 million in 2022, then soared by 570.79% to $41.7 million in 2023, then rose by 20.05% to $50.1 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Non-Current Debt are $50.1 million (Q4 2024), $41.7 million (Q4 2023), and $6.2 million (Q4 2022).